[email protected]14 Oct, 2021News
India's first indigenous mRNA Covid-19 vaccine candidate, which is being developed by Pune-based Gennova Biopharmaceuticals Limited, has been found safe, tolerable, and immunogenic in the participants of the phase-1 study. Gennova Biopharmaceuticals had submitted the interim clinical data of the Phase I study of the vaccine to the Central Drugs Standard Control Organisation (CDSCO), which is the Indian drug regulatory authority.
Integrity Restrooms
Ramatech Machine Tools
88aa
Rcrisp Solutions India Pvt. Ltd.
Aspire Holidays
Futk Olik
Business Manager
888p – Trang Chủ Nhà Cái Uy Tín 888p Uk Com
Chiku Cab
Jk Plumbing